Efficacy and safety of oral fludarabine/cyclophosphamide regimen in previously treated indolent lymphomas

Leuk Lymphoma. 2005 Dec;46(12):1839-41. doi: 10.1080/10428190500264421.
No abstract available

Publication types

  • Clinical Trial
  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Cyclophosphamide / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Lymphoma / drug therapy*
  • Lymphoma / pathology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Time Factors
  • Treatment Outcome
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives*

Substances

  • Cyclophosphamide
  • Vidarabine
  • fludarabine